Cellectar Biosciences, Inc. · NASDAQ:CLRB
Cellectar Biosciences, Inc. shareholders
As of Sep 30, 2026, 27 institutions reported holding Cellectar Biosciences, Inc., 46.3% of its shares. Largest: Empery Asset Management, LP, Stonepine Capital Management, LLC and Caligan Partners LP. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Cellectar Biosciences, Inc. | Change | Filed |
|---|---|---|---|---|
| Empery Asset Management, LP | 955K | 9.5% | +766K | Nov 16, 2026 |
| Stonepine Capital Management, LLC | 749K | 7.5% | +644K | Nov 13, 2026 |
| Caligan Partners LP | 470K | 4.7% | no change | Nov 16, 2026 |
| Janus Henderson | 466K | 4.6% | first report | Nov 16, 2026 |
| Stempoint Capital LP | 447K | 4.5% | +92,422 | Nov 16, 2026 |
| Vanguard | 357K | 3.6% | −16,469 | Nov 13, 2026 |
| Bleichroeder LP | 289K | 2.9% | no change | Nov 13, 2026 |
| Balyasny Asset Management L.P. | 220K | 2.2% | no change | Nov 16, 2026 |
| Nantahala Capital Management, LLC | 220K | 2.2% | −220K | Nov 13, 2026 |
| Silverarc Capital Management, LLC | 151K | 1.5% | −171K | Nov 12, 2026 |